The prognostic value of the presence of fusion gene PAX3-FOXO1 in alveolar rhabdomyosarcoma is still under debate and a latest meta-analysis did not find significant difference in overall survival between patients with the positive and negative fusion gene. The gene discussed is PAX3; the disease is rhabdomyosarcoma.